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expression under the control of a 
ubiquitous promoter produced a NOS 
immuno-reactive band at 175 kD 
(Figure 1C´), but had no obvious 
effect on the flies. Expression of this 
transgene did not rescue the lethality 
associated with the original NosC 
chromosome. While it is possible that 
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Nitric oxide (NO) is a key regulator 
of diverse biological processes, 
including the modulation of blood 
vessel tone [1]. Nitric oxide synthase 
(NOS), which oxidizes arginine to 
produce NO and citrulline [2], is 
found in organisms from bacteria to 
humans. Despite the impact of NO 
on physiology, mice lacking all three 
mammalian NOS isoforms develop 
to term and are viable [3]. There is a 
single NOS ortholog encoded in the 
Drosophila genome (Nos). Regulski 
et al. [4] described a mutation in a 
conserved residue that abrogates 
NOS activity, and reported that 
this lesion confers lethality (NosC). 
However, two lines of evidence led us 
to believe that this lethality could be 
due to a closely associated mutation 
rather than the lesion in Nos itself. 
First, the lethality was not rescued by 
reintroduction of NOS. Second, while 
the authors convincingly demonstrate 
that they have generated a mutation 
in the Nos gene that inactivates 
the enzyme, they do so for only 
one of the 17 alleles that they 
assign to the Nos complementation 
group. Beginning with a stock 
of NosC provided by Regulski et 
al. [4], we isolated recombinant 
chromosomes in which we separated 
the lethal lesion from the point 
mutation in NosC. Additionally, we 
generated a deletion that removes 
significant portions of the Nos 
coding sequences, including those 
responsible for synthesis of NO, and 
found it to be homozygous viable. 
Both our deletion and NosC eliminate 
NOS enzymatic activity without 
affecting Drosophila development, 
and without obviously compromising 
the health of the flies. 
We created a transgenic line 
carrying the Nos cDNA (Dijkers and 
O’Farrell, unpublished data). Its 
Correspondences
the transgene is not expressed in a 
way that is spatially and temporally 
appropriate for complete rescue, its 
expression did not even modify the 
stage of lethality, suggesting that 
the lethality associated with NosC 
is not the direct consequence of a 
deficiency in NOS function. 
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Figure 1. Characterization of a deletion of the Nos oxygenase domain. 
(A) The Drosophila Nitric Oxide Synthase genomic region. Transcript NOS-RA with its exons enu-
merated and its coding region shaded (transcript orientation from right to left follows the genom-
ic map). NosD15 is a deletion of the region between PBac{WH}Nosf02469 and PBac{RB}Nose02671. 
NosD15 also deletes CG6508 and CG17134 (depicted). Since the deletion exhibits no evident 
phenotype, these two coding sequences also appear dispensable. The asterisk represents the 
point mutation associated with NosC. (B) PCR amplification of genomic sequences PCR A and 
B, and a control region that lies outside the Nos locus. Shown here are five candidate recom-
binants; candidates two and three are deleted for the region between PBac{WH}Nosf02469 and 
PBac{RB}Nose02671. (B´) RT-PCR directed against the indicated exons confirmed the absence of 
the oxygenase domain in NosD15; a transcript that includes exons 15–18 is expressed in the dele-
tion strain. (C) NOS activity of extracts from adult heads; activity is represented by the amount 
of [3H]citrulline as a percent of the total [3H] recovered (arginine + citrulline); L-NNA is the NOS 
inhibitor, NG-nitro-L-Arginine; asterisk indicates significant reduction in NOS activity compared 
to w1118 uninhibited control (p < 0.005). (C´) Western blotting of the extracts used for NOS activity 
assays reveals the levels of NOS (black arrowhead); β-Tubulin is used as a loading control (white 
arrowhead). Over-expression of NOS driven from the transgene results in several minor bands 
that are smaller than the main band at 175 kD. These bands are not visible in other sample types 
and therefore are unlikely to correspond to endogenously produced isoforms. (D) NADPH-dia-
phorase reactivity in w1118 and NosD15 wing discs.
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Since NosC was selected as a 
lethal over a deletion that removed 
five nearby open reading frames 
(ORFs) as well as Nos 5´ sequences, 
it seemed possible that a second 
change in one of these five ORFs 
might be the cause of the lethality 
associated with NosC. Such a closely 
linked secondary mutation would 
not have been easily separated 
by backcrossing. We exploited an 
insertion element within the Nos 
locus (PBac{WH}Nosf02469, Figure 
1A) to isolate viable recombinant 
chromosomes that were likely to 
retain the NosC mutation. Sequence 
analysis confirmed that the newly 
isolated chromosomes carry the 
substitution described by Regulski 
et al. [4]. We obtained three 
recombinant chromosomes, giving a 
separation of roughly 0.08 map units 
(~22 kb) between the lethal and the 
NosC lesion (Supplemental Data). 
Importantly, flies homozygous for this 
purified NosC isolate are viable. 
To further test the requirement for 
NOS, we produced a new mutation 
by inducing directed recombination 
events between two insertion 
elements, one that is upstream of 
the Nos protein coding sequence 
(PBac{RB}Nose02671) and one that 
is between the fourteenth and 
fifteenth exons (PBac{WH}Nosf02469) 
(Figure 1A). We isolated candidate 
recombinant chromosomes without 
selection, and used PCR to identify 
three lines that carry deletions 
within Nos (Figure 1A,B). One of 
these, which we refer to as NosD15, 
was selected for further analysis. 
NosD15 homozygotes produced a 
truncated RNA corresponding to the 
3´ half of the coding sequence, as 
determined by reverse transcriptase-
polymerase chain reaction (RT-PCR) 
(Figure 1B´). However, this transcript 
lacks translation start sequences 
and we detected no protein product 
(Figure 1C´). We cannot rigorously 
eliminate the possibility that these 
residual sequences encode a vital 
function, but these data suggest 
it is unlikely. Notably, flies that are 
homozygous for this deletion are viable 
and display no discernible defects. 
Furthermore, flies carrying NosD15 in 
transheterozygous combination with 
NosC are similarly viable.
The NosD15 deletion removes 
sequences encoding residues 1–757, 
encompassing the entire oxygenase 
domain and including regions that 
bind the catalytic heme and the 
substrate (arginine). These sequences 
produce a protein structure that is 
uniquely dedicated to NOS catalytic 
activity [5,6]. We wanted to confirm 
the functional disruption of NOS 
activity in both NosD15 and in our new 
isolate of NosC. NOS generates NO 
through the stoichiometric conversion 
of L-arginine to L-citrulline [2]. We 
assayed extracts prepared from 
homozygous NosD15 and NosC adult 
heads for their abilities to stimulate 
this conversion. NOS enzymatic 
activity was reduced in both NosD15 
and NosC homozygotes  to a level 
comparable to negative controls that 
lacked extract or included a NOS 
inhibitor (Figure 1C). 
To generate NO from L-arginine, 
NOS reduces and activates its 
catalytic heme by oxidizing NADPH. 
The diaphorase reaction reveals 
oxidation of NAPH histochemically. 
Although numerous oxidoreductases 
catalyze NADPH oxidation, 
diaphorase staining is often attributed 
specifically to NOS. This is based 
on the observation that diaphorase 
staining and NOS distribution are 
coincident in the mammalian brain, 
particularly in tissue that is fixed with 
paraformaldehyde [7,8]. Interestingly, 
we found that NADPH-diaphorase 
staining in NosD15 wing discs 
(Figure 1D) and gut (not shown) is 
comparable to wild type, indicating 
oxido-reductase activity remains in 
these NOS-deficient tissues. This 
activity might represent any of a 
variety of oxido-reductases. Indeed, 
even though we did not detect the 
protein product, it is possible that low 
levels of expression of the carboxy-
terminal reductase domain of NOS, 
which we did not delete, contribute 
to this activity. However, regardless 
of the source of this activity, it occurs 
in the absence of the NOS catalytic 
center and NO production. These 
results underscore the caveats 
associated with the use of the 
NADPH-diaphorase reactivity as a 
measure of NOS activity. 
Our results show that the 
recognized Drosophila orthologue of 
NOS is non-essential. The absence 
of any other Drosophila sequence 
related to the NOS catalytic domain 
suggests that NOS activity itself 
is non-essential. Since NO can be 
produced by NOS-independent 
reduction of nitrite, a reaction 
carried out by microbes and 
eukaryotic mitochondria, it remains 
possible that NO has an important 
role in Drosophila despite NOS 
dispensability [9]. NOS is conserved 
from prokaryotes [10] to humans. 
This preservation during evolution 
suggests a role for the enzymatic 
activity, but it is dispensable at 
least in the context of unperturbed 
Drosophila development in the lab 
environment.
Supplemental Data
Supplemental data are available at http://
www.cell.com/current-biology/supplemen-
tal/S0960-9822(09)02130-7
Acknowledgements
We would like to thank S. Deluca, J. Farrell, 
M. McCleland and J. Ward for critically 
reading the manuscript. E.A.S. is supported 
by a fellowship from the Canadian 
Institutes of Health Research. The work 
was supported by a grant from the National 
Institutes of Health GM08654 to P.H.O’F.
References
 1.  Ignarro, L.J. (1999). Nitric oxide: a unique 
endogenous signaling molecule in vascular 
biology. Biosci. Rep. 19, 51–71.
 2.  Zhu, Y., and Silverman, R.B. (2008). Revisiting 
heme mechanisms. A perspective on the 
mechanisms of nitric oxide synthase (NOS), 
Heme oxygenase (HO), and cytochrome P450s 
(CYP450s). Biochemistry 47, 2231–2243.
 3.  Tsutsui, M., Shimokawa, H., Morishita, T., 
Nakashima, Y., and Yanagihara, N. (2006). 
Development of genetically engineered mice 
lacking all three nitric oxide synthases. J. 
Pharmacol. Sci. 102, 147–154.
 4.  Regulski, M., Stasiv, Y., Tully, T., and 
Enikolopov, G. (2004). Essential function of 
nitric oxide synthase in Drosophila. Curr. Biol. 
14, R881–R882.
 5.  Li, H., Igarashi, J., Jamal, J., Yang, W., and 
Poulos, T.L. (2006). Structural studies of 
constitutive nitric oxide synthases with 
diatomic ligands bound. J. Biol. Inorg. Chem. 
11, 753–768.
 6.  Gorren, A., and Mayer, B. (2007). Nitric-oxide 
synthase: A cytochrome P450 family foster 
child. Biochim. Biophys. Acta 1770, 432–445.
 7.  Hope, B.T., Michael, G.J., Knigge, K.M., 
and Vincent, S.R. (1991). Neuronal NADPH 
diaphorase is a nitric oxide synthase. Proc. 
Natl. Acad. Sci. USA 88, 2811–2814.
 8.  Matsumoto, T., Nakane, M., Pollock, J., Kuk, 
J., and Förstermann, U. (1993). A correlation 
between soluble brain nitric oxide synthase 
and NADPH-diaphorase activity is only 
seen after exposure of the tissue to fixative. 
Neurosci. Lett. 155, 61–64.
 9.  Poyton, R.O., Castello, P.R., Ball, K.A., Woo, 
D.K., and Pan, N. (2009). Mitochondria and 
hypoxic signaling: a new view. Ann. NY Acad. 
Sci. 1177, 48–56.
 10.  Gusarov, I., Starodubtseva, M., Wang, Z.-Q., 
McQuade, L., Lippard, S.J., Stuehr, D.J., 
and Nudler, E. (2008). Bacterial nitric-oxide 
synthases operate without a dedicated redox 
partner. J. Biol. Chem. 283, 13140–13147.
Department of Biochemistry, University of 
California at San Francisco, San Francisco, 
CA 94158, USA.  
E-mail: ofarrell@cgl.ucsf.edu
